<SEC-DOCUMENT>0001564590-16-019256-index.html : 20160512 <SEC-HEADER>0001564590-16-019256.hdr.sgml : 20160512 <ACCEPTANCE-DATETIME>20160512165159 ACCESSION NUMBER: 0001564590-16-019256 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20160512 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160512 DATE AS OF CHANGE: 20160512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cidara Therapeutics, Inc. CENTRAL INDEX KEY: 0001610618 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461537286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36912 FILM NUMBER: 161644665 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-752-6170 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: K2 THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140611 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>cdtx-8k_20160512.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: cdtx-8k_20160512.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>cdtx-ex991_56.htm <DESCRIPTION>EX-99.1 EARNINGS RELEASE <TEXT> Document 2 - file: cdtx-ex991_56.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>gyjma0diqbu1000001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: gyjma0diqbu1000001.jpg
</DOCUMENT> </SEC-DOCUMENT>